Log in or Sign up for Free to view tailored content for your specialty!
Ocular Oncology News
UCLA researchers receive $1 million to develop novel CAR T-cell therapies for melanoma
Cristina Puig-Saus, PhD, and Daniel S. Shin, MD, PhD, of UCLA Jonsson Comprehensive Cancer Center received a $1 million award from the U.S. Department of Defense for research into novel cell therapies for rare melanomas.
FDA grants priority review to tebentafusp for metastatic uveal melanoma
The FDA granted priority review to tebentafusp for treatment of adults with HLA-A*02:01-positive metastatic uveal melanoma.
Log in or Sign up for Free to view tailored content for your specialty!
Man experiences acute unilateral loss of vision
A 68-year-old man was referred to the New England Eye Center neuro-ophthalmology clinic for evaluation of acute loss of vision in the left eye.
Man presents with daily headaches and blurry vision
A 39-year-old man presented to the comprehensive ophthalmology service at the New England Eye Center with 6 weeks of daily headaches and blurry vision.
Radiotherapy may not improve outcomes in uveal melanoma with extraocular extension
There was no significant difference in survival in eyes that underwent enucleation for uveal melanoma with extraocular extension between postoperative orbital external beam radiotherapy vs. observation, according to a poster presentation.
Woman presents with vision changes, orbital mass
A 43-year-old stay-at-home mom was referred to the Tufts New England Eye Center for a newly identified orbital mass and vision changes in her right eye.
Chemotherapy may offer alternative to enucleation in certain retinoblastoma cases
A conservative approach can be considered as a safe alternative to primary enucleation in children with advanced retinoblastoma in some cases, according to a presenter.
Young woman presents with conjunctival lesion of right eye
A 26-year-old woman was referred to the Lahey Clinic for evaluation of a recurrent conjunctival lesion of the right eye.
Glaucoma may develop after plaque radiotherapy for iris melanoma
Patients with iris melanoma treated with plaque radiotherapy were more likely to develop post-management glaucoma than when other conservative treatments were used, according to a speaker.
Phase 2 study of AU-011 for primary choroidal melanoma underway
The first patient has been dosed in a phase 2 clinical trial investigating safety and efficacy of suprachoroidal administration of AU-011 as a potential treatment for primary choroidal melanoma, according to a press release.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read